Cochrane Abstracts
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Leukoreduction for the Prevention of Adverse Reactions From Allogeneic Blood Transfusion." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439195/all/Leukoreduction_for_the_prevention_of_adverse_reactions_from_allogeneic_blood_transfusion.
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439195/all/Leukoreduction_for_the_prevention_of_adverse_reactions_from_allogeneic_blood_transfusion. Accessed March 21, 2025.
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439195/all/Leukoreduction_for_the_prevention_of_adverse_reactions_from_allogeneic_blood_transfusion
Leukoreduction for the Prevention of Adverse Reactions From Allogeneic Blood Transfusion [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439195/all/Leukoreduction_for_the_prevention_of_adverse_reactions_from_allogeneic_blood_transfusion.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion
ID - 439195
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439195/all/Leukoreduction_for_the_prevention_of_adverse_reactions_from_allogeneic_blood_transfusion
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
